Baudax Bio, Inc. Profile Avatar - Palmy Investing

Baudax Bio, Inc.

Baudax Bio, Inc., a pharmaceutical company, develops and commercializes products for hospital and other acute care settings. The company offers ANJESO (meloxicam) injection for the management of moderate to severe pain, alone or in combination with non-N…

Biotechnology
US, Malvern [HQ]
US · Macroeconomic Factors/Risks · Forecasts

Macro

Baudax Bio, Inc. mainly operates in US (Alpha-2: US, Alpha-3: USA)

United States
Analysis Results
B Overall Rating
19 Analyzed Indicators
B Annual Indicators Rating
16 Analyzed Indicators
B+ Monthly Indicators Rating
3 Analyzed Indicators
Breakdown

All indicators comes from high quality sources, such as the world bank, OECD, FRED and manuel datasets such as Premiums by Prof. Damodaran.

End of BXRX's Analysis
CIK: 1780097 CUSIP: 07160F206 ISIN: US07160F4046 LEI: - UEI: -
Secondary Listings
BXRX has no secondary listings inside our databases.